Technology
Health
Medical

GenMark Diagnostics

$7.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.67%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell GNMK and other stocks, options, ETFs, and crypto commission-free!

About

GenMark Diagnostics, Inc. Common Stock, also called GenMark Diagnostics, is a molecular diagnostics company, which engages in the provision of multiplex molecular diagnostic solutions. Read More Its products include ePlex and XT-8. The company was founded by Jon Faiz Kayyemin 1993 and is headquartered in Carlsbad, CA.

Employees
477
Headquarters
Carlsbad, California
Founded
1993
Market Cap
416.74M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
339.18K
High Today
$7.51
Low Today
$7.29
Open Price
$7.40
Volume
99.86K
52 Week High
$8.81
52 Week Low
$3.58

Collections

Technology
Health
Medical
US
North America

News

Simply Wall St12h

Should You Worry About GenMark Diagnostics, Inc.’s (NASDAQ:GNMK) CEO Pay Cheque?

Hany Massarany became the CEO of GenMark Diagnostics, Inc. (NASDAQ:GNMK) in 2011. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Then we’ll look at a snap shot of the business growth. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. The aim of all this is to consider the appropriateness of CEO pay levels. View our latest analysis for GenMark Diagnos...

9
Simply Wall StMar 7

Should You Investigate GenMark Diagnostics, Inc. (NASDAQ:GNMK) At US$7.38?

GenMark Diagnostics, Inc. (NASDAQ:GNMK), which is in the medical equipment business, and is based in United States, saw a significant share price rise of over 20% in the past couple of months on the NASDAQGM. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. But what if there is still an opportunity to buy? Let’s take a look at GenMark Diagnostics’s outlook and value based on the most recent financial data to see i...

14
MarketBeatMar 5

Stock Price, News, & Analysis for GenMark Diagnostics

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagn...

2

Earnings

-$0.37
-$0.30
-$0.24
-$0.17
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.